Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)

NCT00467597 · clinicaltrials.gov ↗

COMPLETED

Status

36

Enrollment

FED

Sponsor class

Conditions

Dyskinesias
Movement Disorders
Parkinson Disease

Interventions

DRUG: Levodopa (delivered intravenously)

Sponsor

US Department of Veterans Affairs

Collaborators

[object Object]